Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants
Citations Over TimeTop 1% of 2021 papers
Abstract
The emergence of highly transmissible SARS-CoV-2 variants of concern (VOCs) that are resistant to therapeutic antibodies highlights the need for continuing discovery of broadly reactive antibodies. We identified four receptor binding domain-targeting antibodies from three early-outbreak convalescent donors with potent neutralizing activity against 23 variants, including the B.1.1.7, B.1.351, P.1, B.1.429, B.1.526, and B.1.617 VOCs. Two antibodies are ultrapotent, with subnanomolar neutralization titers [half-maximal inhibitory concentration (IC50) 0.3 to 11.1 nanograms per milliliter; IC80 1.5 to 34.5 nanograms per milliliter). We define the structural and functional determinants of binding for all four VOC-targeting antibodies and show that combinations of two antibodies decrease the in vitro generation of escape mutants, suggesting their potential in mitigating resistance development.
Related Papers
- → SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma(2021)1,264 cited
- → Quantitative determination of mechanical stability in the novel coronavirus spike protein(2020)67 cited
- → Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma(2021)54 cited
- → Neutralization breadth and potency of serum derived from recently human immunodeficiency virus type 1-infected Thai individuals(2016)1 cited
- → Heterogeneity in the Properties of 7 S and 19 S Rabbit-Neutralizing Antibodies to Herpes Simplex Virus(1968)101 cited